Levalbuterol is a bronchodilator. Xopenex is a short-acting beta-agonist. It works by resting muscles in the airways to improve breathing. Levalbuterol inhalation is used to treat rescindable obstructive airway conditions such as asthma, bronchitis, and emphysema. Xopenex (levalbuterol HCl) Inhalation Solution is a short-acting bronchodilator used in the treatment or prophylactication of bronchospasm in patients 6 years of age.
Levalbuterol HCl is the USAN mutated name for (R)-albuterol HCl in the United States. Xopenex (levalbuterol HCl) Inhalation Solution is supplied in unit-dose vials and needs no dilution before administration by nebulization. Patients receiving the higher dose of Xopenex Inhalation Solution should be monitored costively for adverse systemic ( A systemic disease such as diabetes can affect the whole body) effects, and the risks of such effects should be balanced against the potential for improved efficacy. Systemic chemotherapy employs drugs which travel through the bloodstream and arrive and affect cells all over the body. Nausea, dry mouth or cough leg cramps, fast/irregular heartbeat, headache, difficulty sleeping is side effect of Levalbuterol.
Side Effects of Levalbuterol
- Dry mouth or cough.
- Leg cramps.
Use of levalbuterol over the more conformistly used racemic albuterol is controversial among health care professionals. Levalbuterol inhalation is not approved for use by children younger than 6 years of age. Patients 12 years of age and older with more acute asthma a dose of 0.63 mg of Xopenex Inhalation. Solution may advantage from a dosage of 1.25 mg three times a day. Symptoms of Levalbuterol overdose may comprise chest pain, fast or irregular heartbeat, headache, tremors, nervousness, weakness, and dizziness. Seek emergency clinical attention.
Warnings and precautions before taking Levalbuterol
Levalbuterol HCl should be used with caveat in patients with cardiovascular disorders, especially coronary insufficiency, hypertension, and cardiac arrhythmias. Large doses of intravenous racemic albuterol have been reported to enhance preexisting diabetes mellitus and ketoacidosis. If the patient requires more doses of Xopenex Inhalation Solution than usual, this may be a marker of destabilization of asthma. Xopenex Inhalation Solution, like all other beta-adrenergic agonists, can produce a medically critical cardiovascular effect in some patients, as cadenced by pulse rate, blood pressure, and/or symptoms.